Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+2.8%
5Y CAGR+79.0%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+2.8%/yr
Annual compound
5Y CAGR
+79.0%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
18.4x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 233.33% |
| 2024 | -400.00% |
| 2023 | -92.42% |
| 2022 | 214.78% |
| 2021 | 11.88% |
| 2020 | 12.71% |
| 2019 | 14.33% |
| 2018 | -74.50% |
| 2017 | -170.27% |
| 2016 | 0.00% |